{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:28:59Z","timestamp":1791912539857,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T00:00:00Z","timestamp":1665187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangdong Provincial High-level Hospital Construction Special Fund","award":["YNKT2021-ZZ10"],"award-info":[{"award-number":["YNKT2021-ZZ10"]}]},{"name":"Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties","award":["SZGSP012"],"award-info":[{"award-number":["SZGSP012"]}]},{"name":"Shenzhen Key Medical Discipline Construction Fund","award":["SZXK032"],"award-info":[{"award-number":["SZXK032"]}]},{"DOI":"10.13039\/501100017607","name":"Shenzhen Fundamental Research Program","doi-asserted-by":"publisher","award":["JCYJ20190809170007587"],"award-info":[{"award-number":["JCYJ20190809170007587"]}],"id":[{"id":"10.13039\/501100017607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A range of public health measures have been implemented to suppress local transmission of coronavirus disease 2019 (COVID-19) in Shenzhen. We examined the effect of these measures on the prevalence of respiratory pathogens in children. Clinical and respiratory pathogen data were collected for routine care from hospitalized children with acute respiratory infections in Shenzhen Children\u2019s Hospital from July 2018 to January 2022. Nasopharyngeal swabs were collected and respiratory pathogens were detected using standardized clinical diagnostics as part of routine care. Data were analyzed to describe the effects of COVID-19 prevention procedures on other common pathogens. A total of 56,325 children under 14\u00a0years of age were hospitalized with an acute respiratory infection during the study period, 33,909 were tested from July 2018 to January 2020 (pre-lockdown), 1168 from February 2020 to May 2020 (lockdown) and 21,248 from July 2020 to January 2022 (post-lockdown). We observed a 37.3% decline of routine care in respiratory infection associated hospital admission in the 19\u00a0months\u2019 post-lockdown vs. the 19\u00a0months\u2019 pre-lockdown. There were 99.4%, 16.0% and 1.26% reductions measured for <jats:italic>Mycoplasma pneumoniae<\/jats:italic>, influenza virus A and adenovirus, respectively. However, a 118.7% and 75.8% rise was found for respiratory syncytial virus (RSV) and human para-influenza virus (HPIV) during the 19\u00a0months\u2019 post-lockdown in comparison to the pre-pandemic period. The detection of RSV especially increased in toddlers after the lockdown. Lockdown measures during the COVID-19 pandemic led to a significant reduction of <jats:italic>Mycoplasma pneumoniae,<\/jats:italic> influenza virus A and adenovirus infection. In contrast, RSV and HPIV infection increased.<\/jats:p>","DOI":"10.1038\/s41598-022-21430-x","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T09:02:59Z","timestamp":1665219779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Lockdown measures during the COVID-19 pandemic strongly impacted the circulation of respiratory pathogens in Southern China"],"prefix":"10.1038","volume":"12","author":[{"given":"Heping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marien I.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilly M.","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,8]]},"reference":[{"issue":"2","key":"21430_CR1","doi-asserted-by":"publisher","first-page":"e2021051462","DOI":"10.1542\/peds.2021-051462","volume":"148","author":"Z Haddadin","year":"2021","unstructured":"Haddadin, Z. et al. Acute respiratory illnesses in children in the SARS-CoV-2 pandemic: Prospective multicenter study. Pediatrics 148(2), e2021051462 (2021).","journal-title":"Pediatrics"},{"issue":"7825","key":"21430_CR2","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-020-2293-x","volume":"585","author":"S Lai","year":"2020","unstructured":"Lai, S. et al. Effect of non-pharmaceutical interventions to contain COVID-19 in China. Nature 585(7825), 410\u2013413 (2020).","journal-title":"Nature"},{"issue":"48","key":"21430_CR3","doi-asserted-by":"publisher","first-page":"30547","DOI":"10.1073\/pnas.2013182117","volume":"117","author":"RE Baker","year":"2020","unstructured":"Baker, R. E. et al. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc. Natl. Acad. Sci. USA 117(48), 30547\u201330553 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"21430_CR4","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3390\/healthcare9101292","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Stringent nonpharmaceutical interventions are crucial for curbing COVID-19 transmission in the course of vaccination: A case study of South and Southeast Asian countries. Healthcare (Basel). 9(10), 1292 (2021).","journal-title":"Healthcare (Basel)."},{"issue":"4","key":"21430_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00103-021-03306-z","volume":"64","author":"U Grote","year":"2021","unstructured":"Grote, U. et al. Measures to cope with the COVID-19 pandemic in Germany: Nonpharmaceutical and pharmaceutical interventions. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 64(4), 435\u2013445 (2021).","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"9","key":"21430_CR6","doi-asserted-by":"publisher","first-page":"ofab415","DOI":"10.1093\/ofid\/ofab415","volume":"8","author":"TM Le\u00f3n","year":"2021","unstructured":"Le\u00f3n, T. M. et al. Nonpharmaceutical interventions remain essential to reducing coronavirus disease 2019 burden even in a well-vaccinated society: A modeling study. Open Forum Infect. Dis. 8(9), ofab415 (2021).","journal-title":"Open Forum Infect. Dis."},{"issue":"7","key":"21430_CR7","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1093\/cid\/ciaa1682","volume":"72","author":"K Huh","year":"2021","unstructured":"Huh, K. et al. Impact of nonpharmaceutical interventions on the incidence of respiratory infections during the coronavirus disease 2019 (COVID-19) outbreak in Korea: A nationwide surveillance study. Clin. Infect. Dis. 72(7), e184\u2013e191 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"21430_CR8","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/1471-2458-7-208","volume":"7","author":"JE Aledort","year":"2007","unstructured":"Aledort, J. E., Lurie, N., Wasserman, J. & Bozzette, S. A. Non-pharmaceutical public health interventions for pandemic influenza: An evaluation of the evidence base. BMC Public Health 7, 208 (2007).","journal-title":"BMC Public Health"},{"issue":"1","key":"21430_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3201\/eid2801.211099","volume":"28","author":"SS Chiu","year":"2022","unstructured":"Chiu, S. S. et al. Effects of nonpharmaceutical COVID-19 interventions on pediatric hospitalizations for other respiratory virus infections, Hong Kong. Emerg. Infect. Dis. 28(1), 62\u201368 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"21430_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.672568","volume":"9","author":"Y Geng","year":"2021","unstructured":"Geng, Y., Li, G. & Zhang, L. The impact of COVID-19 interventions on influenza and mycobacterium tuberculosis infection. Front. Public Health 9, 672568 (2021).","journal-title":"Front. Public Health"},{"issue":"1","key":"21430_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12985-021-01669-y","volume":"18","author":"L Li","year":"2021","unstructured":"Li, L. et al. Comparison of 11 respiratory pathogens among hospitalized children before and during the COVID-19 epidemic in Shenzhen, China. Virol. J. 18(1), 202 (2021).","journal-title":"Virol. J."},{"key":"21430_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2021.100282","volume":"17","author":"J Xiao","year":"2021","unstructured":"Xiao, J. et al. Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: A large population-based observational study. Lancet Reg. Health West Pac. 17, 100282 (2021).","journal-title":"Lancet Reg. Health West Pac."},{"issue":"1","key":"21430_CR13","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41467-021-21157-9","volume":"12","author":"QS Huang","year":"2021","unstructured":"Huang, Q. S. et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat. Commun. 12(1), 1001 (2021).","journal-title":"Nat. Commun."},{"issue":"11","key":"21430_CR14","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jiac.2021.07.024","volume":"27","author":"Y Fukuda","year":"2021","unstructured":"Fukuda, Y. et al. Surveillance in hospitalized children with infectious diseases in Japan: Pre- and post-coronavirus disease 2019. J. Infect. Chemother. 27(11), 1639\u20131647 (2021).","journal-title":"J. Infect. Chemother."},{"key":"21430_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100103","volume":"6","author":"A Ullrich","year":"2021","unstructured":"Ullrich, A. et al. Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1\u20132016\u2014week 32\u20132020. Lancet Reg. Health Eur. 6, 100103 (2021).","journal-title":"Lancet Reg. Health Eur."},{"issue":"14","key":"21430_CR16","doi-asserted-by":"publisher","first-page":"2000326","DOI":"10.2807\/1560-7917.ES.2020.25.14.2000326","volume":"25","author":"PY Bo\u00eblle","year":"2020","unstructured":"Bo\u00eblle, P. Y. et al. Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020. Euro Surveill. 25(14), 2000326 (2020).","journal-title":"Euro Surveill."},{"issue":"19","key":"21430_CR17","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1001\/jama.2020.6173","volume":"323","author":"H Sakamoto","year":"2020","unstructured":"Sakamoto, H., Ishikane, M. & Ueda, P. Seasonal influenza activity during the SARS-CoV-2 outbreak in Japan. JAMA 323(19), 1969\u20131971 (2020).","journal-title":"JAMA"},{"issue":"8","key":"21430_CR18","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.3201\/eid2608.201229","volume":"26","author":"R Soo","year":"2020","unstructured":"Soo, R. et al. Decreased influenza incidence under COVID-19 control measures, Singapore. Emerg. Infect. Dis. 26(8), 1933\u20131935 (2020).","journal-title":"Emerg. Infect. Dis."},{"issue":"9","key":"21430_CR19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3855\/jidc.13250","volume":"14","author":"E Murillo-Zamora","year":"2020","unstructured":"Murillo-Zamora, E. et al. Physical distancing reduced the incidence of influenza and supports a favorable impact on SARS-CoV-2 spread in Mexico. J. Infect. Dev. Ctries. 14(9), 953\u2013956 (2020).","journal-title":"J. Infect. Dev. Ctries."},{"key":"21430_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.puhe.2020.10.011","volume":"189","author":"W Cheng","year":"2020","unstructured":"Cheng, W. et al. Successful interruption of seasonal influenza transmission under the COVID-19 rapid response in Zhejiang Province, China. Public Health 189, 123\u2013125 (2020).","journal-title":"Public Health"},{"issue":"5","key":"21430_CR21","doi-asserted-by":"publisher","first-page":"e279","DOI":"10.1016\/S2468-2667(20)30090-6","volume":"5","author":"BJ Cowling","year":"2020","unstructured":"Cowling, B. J. et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: An observational study. Lancet Public Health 5(5), e279\u2013e288 (2020).","journal-title":"Lancet Public Health"},{"issue":"29","key":"21430_CR22","doi-asserted-by":"publisher","first-page":"2001600","DOI":"10.2807\/1560-7917.ES.2021.26.29.2001600","volume":"26","author":"S Tempia","year":"2021","unstructured":"Tempia, S. et al. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020. Euro Surveill. 26(29), (2021).","journal-title":"Euro Surveill."},{"issue":"1","key":"21430_CR23","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1038\/s41467-021-23440-1","volume":"12","author":"L Feng","year":"2021","unstructured":"Feng, L. et al. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nat. Commun. 12(1), 3249 (2021).","journal-title":"Nat. Commun."},{"issue":"6","key":"21430_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006419","volume":"13","author":"N Latorre-Margalef","year":"2017","unstructured":"Latorre-Margalef, N. et al. Competition between infuenza A virus subtypes through heterosubtypic immunity modulates re-infection and antibody dynamics in the mallard duck. PLoS Pathog. 13(6), e1006419 (2017).","journal-title":"PLoS Pathog."},{"issue":"11","key":"21430_CR25","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1093\/infdis\/jiaa570","volume":"222","author":"H Lei","year":"2020","unstructured":"Lei, H. et al. Nonpharmaceutical interventions used to control COVID-19 reduced seasonal influenza transmission in China. J. Infect. Dis. 222(11), 1780\u20131783 (2020).","journal-title":"J. Infect. Dis."},{"issue":"3","key":"21430_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.14745\/ccdr.v47i03a04","volume":"47","author":"P Lagac\u00e9-Wiens","year":"2021","unstructured":"Lagac\u00e9-Wiens, P. et al. Impact of nonpharmaceutical interventions on laboratory detections of influenza A and B in Canada. Can. Commun. Dis. Rep. 47(3), 142\u2013148 (2021).","journal-title":"Can. Commun. Dis. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21430-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21430-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21430-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T10:09:18Z","timestamp":1665223758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21430-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,8]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21430"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21430-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,8]]},"assertion":[{"value":"26 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16926"}}